MENU

How I’d invest $10,000 today

Donald Trump’s potential tariffs on China are causing the market to be very fearful about what could be coming next.

But, as the saying goes, it could be time to be greedy with the stock market showing red across the board.

If I had $10,000 to invest today, this is what I’d do with it:

National Veterinary Care Ltd (ASX: NVL) – $3,000

National Veterinary Care is down by 3.98% today. What does tariffs on China have to do with people taking their pet to the vet in Australia? I’m not sure either. This fast-growing vet business is rapidly using funds to buy more vet clinics to add to its network. I think it is one of the best small caps on the ASX at the moment.

Challenger Ltd (ASX: CGF) – $3,000

Challenger is down 1.92% today. Declines in capital markets do have an effect on Challenger, but it shouldn’t affect the demand for annuities. In-fact, it could increase demand because retirees want a secure source of income for their capital, they don’t want volatility. I think Challenger is the best finance stock on the ASX, which is why it’s one of my biggest holdings.

Magellan Global Trust (ASX: MGG) – $4,000

The Magellan Global Trust is down 1.97%. There are few managers on the ASX that have done better over the past 10 years than Magellan Financial Group Ltd (ASX: MFG). This trust is heavily exposed to the biggest US businesses and some of its largest investments include Apple and Alphabet. I think it will do well out of this volatility because it keeps a good percentage of its portfolio as cash for protection and opportunities.

Foolish takeaway

I believe all three of these shares will comfortably beat the market over the next two to three years. At the current prices it’s hard to pick one as a clear winner because they all look good value to me, I’d really like to add more of each share to my portfolio.

This top stock could be an even better buy with today’s volatility.

OUR #1 dividend pick to grow your wealth over the new financial year is revealed for FREE here!

Financial year 2018 is here and The Motley Fool’s dividend detective Andrew Page has revealed his must buy dividend share to grow your wealth in 2018.

You might not know this market leader's name, but it's rapidly expanding into a highly profitable niche market here in Australia. Even better, the shares boast a strong, fully franked dividend that should balloon in the years to come. In other words, we're looking at the holy grail of incredible long-term growth potential AND income you can watch accruing in your account in real time!

Simply click here to grab your FREE copy of this up-to-the-minute research report on our #1 dividend share recommendation now.

Motley Fool contributor Tristan Harrison owns shares of Challenger Limited, MAGLOBTRST UNITS, and NATVETCARE FPO. The Motley Fool Australia owns shares of and has recommended Challenger Limited. The Motley Fool Australia owns shares of NATVETCARE FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!